ADAR1 Capital Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2K | Hold |
115,867
| – | – | 0.01% | 185 |
|
|
2025
Q1 | $36.1K | Sell |
115,867
-14,665
| -11% | -$4.57K | 0.01% | 178 |
|
|
2024
Q4 | $122K | Buy |
130,532
+92,789
| +246% | +$86.6K | 0.02% | 165 |
|
|
2024
Q3 | $44.5K | Buy |
37,743
+18,553
| +97% | +$21.9K | 0.01% | 206 |
|
|
2024
Q2 | $14.8K | Buy |
19,190
+2,744
| +17% | +$2.11K | ﹤0.01% | 211 |
|
|
2024
Q1 | $50.2K | Buy |
16,446
+3,200
| +24% | +$9.76K | 0.01% | 163 |
|
|
2023
Q4 | $42.7K | Buy |
+13,246
| New | +$42.7K | 0.02% | 104 |
|